Industry News
Palbociclib shows promise in patients with hormone-resistant breast cancer
Feb 25, 2015
Targeted therapy drug recently approved by FDA for use in newly metastatic breast cancer patientsPalbociclib, an investigational oral medication that works by blocking molecules responsible for... Read More
Lack of awareness of ovarian cancer symptoms, especially among women at greatest risk
Feb 24, 2015
Cancer Australia survey findings released for Teal Ribbon Day, show that 45 per cent of women surveyed were unable to identify any symptom of ovarian cancer, with women at greatest risk, aged 60... Read More
Discovery of the genetic fingerprint of aggressive colon tumours
Feb 24, 2015
About 40-50% of all colorectal patients relapse in the form of metastasis. In the last three years, several molecular classifications have been proposed to identify colorectal cancer patients at... Read More
Lack of awareness of ovarian cancer symptoms, especially among women at greatest risk
Feb 24, 2015
Cancer Australia survey findings released for Teal Ribbon Day, show that 45 per cent of women surveyed were unable to identify any symptom of ovarian cancer, with women at greatest risk, aged 60... Read More
Discovery of the genetic fingerprint of aggressive colon tumours
Feb 24, 2015
About 40-50% of all colorectal patients relapse in the form of metastasis. In the last three years, several molecular classifications have been proposed to identify colorectal cancer patients at... Read More
New HPV approved after international phase 2/3 trial involving Moffitt Cancer Center
Feb 24, 2015
Vaccine protects boys and girls against nine HPV types known to cause cancer and other diseasesApproximately 12,000 women are diagnosed with cervical cancer each year in the United States and... Read More
Simoctocog alfa for haemophilia A: No suitable data
Feb 24, 2015
Duration of direct comparator studies too short, study pool on comparator therapy incompleteSimoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A... Read More
New HPV approved after international phase 2/3 trial involving Moffitt Cancer Center
Feb 24, 2015
Vaccine protects boys and girls against nine HPV types known to cause cancer and other diseasesApproximately 12,000 women are diagnosed with cervical cancer each year in the United States and... Read More
Simoctocog alfa for haemophilia A: No suitable data
Feb 24, 2015
Duration of direct comparator studies too short, study pool on comparator therapy incompleteSimoctocog alfa (trade name Nuwiq) has been approved since July 2014 for people with type A... Read More
New target for prostate cancer treatment discovered by Keck Medicine of USC researchers
Feb 24, 2015
Keck Medicine of the University of Southern California (USC) scientists have found a promising new therapeutic target for prostate cancer. Read More
Previous Page Next Page